What is the Org number of PHARMAQ ANALYTIQ AS?

PHARMAQ ANALYTIQ AS is registered with Brønnøysundsregistrene under Org 982749042.

What is the revenue of PHARMAQ ANALYTIQ AS?

PHARMAQ ANALYTIQ AS reported revenue of NOK 88,6M in 2024.

How many employees does PHARMAQ ANALYTIQ AS have?

PHARMAQ ANALYTIQ AS employs 58 people as of the latest annual report.

Who is the chairman of PHARMAQ ANALYTIQ AS?

Nils Arne Grønlie chairs the board of PHARMAQ ANALYTIQ AS, in role since 2021.

Where is PHARMAQ ANALYTIQ AS headquartered?

PHARMAQ ANALYTIQ AS's registered address is Thormøhlens Gate 53D, 5006 Bergen.

PHARMAQ ANALYTIQ AS

ASActive

Org 982749042Thormøhlens Gate 53D, 5006 BergenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200058 employeeswww.pharmaq-analytiq.com

Full Risika report

Revenue 2024

NOK 88,6M

+2% vs 2023

EBITDA margin

-1.1%

-119% vs 2023

Equity ratio

45.7%

Financial strength

Net profit 2024

NOK -4,1M

-667% vs 2023

EBITDA — year on yearNOK millions

Key figuresAnnual report 2024

Revenue	NOK 88,6M	+2%
EBITDA	NOK -956K	-119%
Net profit	NOK -4,1M	-667%
Total assets	NOK 45,8M	+13%
Equity	NOK 20,9M	+3%
Employees	58	—

Item	2020	2021	2022	2023	2024
Revenue	55 429	82 604	78 756	86 743	88 569
Staff expenses	−24 625	−41 777	−43 367	−43 956	−47 600
EBITDA	−2 726	−88	−2 224	4 980	−956
Depreciation & amort.	−2 664	−3 543	−3 675	−5 007	−3 641
EBIT	−5 390	−3 631	−5 898	−27	−4 597
Net financials	−95	−230	−481	−674	−680
Profit before tax	−5 485	−3 861	−6 379	−700	−5 277
Tax	−1 203	−872	−1 532	−164	−1 162
Net profit	−4 281	−2 989	−4 847	−537	−4 115

Item	2020	2021	2022	2023	2024
Total assets	49 527	57 212	50 285	40 398	45 797
Equity	13 127	20 256	20 862	20 326	20 932
Long-term debt	609	415	421	221	390
Short-term debt	35 791	36 541	29 002	19 852	24 475
Total debt	36 400	36 956	29 423	20 072	24 865

Name	Role	Member since
Current (3)
NA Nils Arne Grønlie	Chairman	2021
BB Ben Backmann	Deputy Chairman	2021
TA Trine Astrid Vatle	Board of Directors	2021
Former (1)
MK Morten Kristoffer Nordstad	Deputy Chairman	2016 – 2021

Shareholder	Type	Ownership	Votes	Since
Zoetis Netherlands 4 B.V.	Company	90.91%	90.91%	2024
Pharmaq Analytiq As	Company	9.09%	9.09%	2024

Person	Role here	Other companies
Nils Arne Grønlie	Chairman	0 companies
Ben Backmann	Deputy Chairman	0 companies
Trine Astrid Vatle	Board of Directors	0 companies
Morten Kristoffer Nordstad	Deputy Chairman	0 companies